Rabies Infection

1 clinical trials · Condition

Record	Firm	Date
Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age (NCT02177032)	Novartis	2014-06-01

Every clearance here is in the API, with alerts when new ones post.